CXCR2 and cancer: For that, we polarized BMDMs with WT 4T1 or E0771 cancer cells and performed Boyden chamber invasion assays with the polarized BMDMs together with WT 4T1 or E0771 cancer cells, with or without the CXCR2 inhibitor SB225002 added to the medium (Figure 6H).